Skip to content
10-K

Annual Report

American CryoStem Corporation

0001019056-21-000028

← back to feed
Filed
Jan 8, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Dec 31, 2020 59.57M sh
Capex FY 2020 · Sep 30, 2019 $20.05K
Operating Cash Flow FY 2020 · Sep 30, 2019 −$496.96K
Current Liabilities FY 2020 · Sep 30, 2019 $1.29M
Total Liabilities FY 2020 · Sep 30, 2019 $2.53M
Current Assets FY 2020 · Sep 30, 2019 $379.81K
Total Assets FY 2020 · Sep 30, 2019 $1.29M
Rd Expense FY 2020 · Sep 30, 2019 $224.79K
Net Income FY 2020 · Sep 30, 2019 −$1.08M
Operating Income FY 2020 · Sep 30, 2019 −$951.04K
Gross Profit FY 2020 · Sep 30, 2019 $289.77K
Cost Of Revenue FY 2020 · Sep 30, 2019 $31.88K
Revenue FY 2020 · Sep 30, 2019 $321.65K
Cash And Equivalents FY 2020 · Sep 30, 2018 $68.32K
Stockholders Equity FY 2020 · Sep 30, 2018 −$700.45K